دورية أكاديمية

Peptide receptor radionuclide therapy of neuroendocrine tumours

التفاصيل البيبلوغرافية
العنوان: Peptide receptor radionuclide therapy of neuroendocrine tumours
المؤلفون: Brabander, Tessa, Teunissen, Jaap, van Eijck, Casper, Franssen, Gaston, Feelders, R.A., de Herder, W.W., Kwekkeboom, Dik
المصدر: Brabander , T , Teunissen , J , van Eijck , C , Franssen , G , Feelders , R A , de Herder , W W & Kwekkeboom , D 2016 , ' Peptide receptor radionuclide therapy of neuroendocrine tumours ' , Best Practice & Research Clinical Endocrinology & Metabolism , vol. 30 , no. 1 , pp. 103-114 . https://doi.org/10.1016/j.beem.2015.10.005Test
سنة النشر: 2016
مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM013901, name=EMC MM-01-39-01, /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM034702A, name=EMC MM-03-47-02-A, /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM044707, name=EMC MM-04-47-07
الوصف: In the past decades, the number of neuroendocrine tumours that are detected is increasing. A relative new and promising therapy for patients with metastasised or inoperable disease is peptide receptor radionuclide therapy (PRRT). This therapy involves an infusion of somatostatin analogues linked to radionuclides like Yttrium-90 or Lutetium-177. Objective response rates are reported in 15-35%. Response rates may vary between type of tumour and radionuclide. Besides the objective response rate, overall survival and progression free survival increase significantly. Also, the quality of life improves as well. Serious side-affects are rare. PRRT is usually well tolerated, also in patients with extensive metastasised disease. Recent studies combined PRRT with other types of therapies. Unfortunately no randomised trials comparing these strategies are available. In the future, more research is needed to evaluate the best therapy combinations or sequence of therapies. (C) 2015 Elsevier Ltd. All rights reserved.
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
العلاقة: https://pure.eur.nl/en/publications/e9405a67-d88e-4f6d-8e6e-b12fad29135fTest
DOI: 10.1016/j.beem.2015.10.005
الإتاحة: https://doi.org/10.1016/j.beem.2015.10.005Test
https://pure.eur.nl/en/publications/e9405a67-d88e-4f6d-8e6e-b12fad29135fTest
حقوق: info:eu-repo/semantics/restrictedAccess
رقم الانضمام: edsbas.AA3A47D8
قاعدة البيانات: BASE